Stephen T Worland - Net Worth and Insider Trading
Stephen T Worland Net Worth
The estimated net worth of Stephen T Worland is at least $1,345 dollars as of 2024-09-21. Stephen T Worland is the President and Chief Executive of eFFECTOR Therapeutics Inc and owns about 31,093 shares of eFFECTOR Therapeutics Inc (EFTR) stock worth over $1,345. Details can be seen in Stephen T Worland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen T Worland has not made any transactions after 2022-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen T Worland
Stephen T Worland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen T Worland owns 3 companies in total, including TRACON Pharmaceuticals Inc (TCON) , GenMark Diagnostics Inc (GNMK) , and eFFECTOR Therapeutics Inc (EFTR) .
Click here to see the complete history of Stephen T Worland’s form 4 insider trades.
Insider Ownership Summary of Stephen T Worland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2015-02-25 | director |
| GNMK | GenMark Diagnostics Inc | 2014-05-29 | director |
| EFTR | eFFECTOR Therapeutics Inc | 2022-06-07 | director & President and Chief Executive |
Stephen T Worland Latest Holdings Summary
Stephen T Worland currently owns a total of 1 stock. Stephen T Worland owns 31,093 shares of eFFECTOR Therapeutics Inc (EFTR) as of June 7, 2022, with a value of $1,345.
Latest Holdings of Stephen T Worland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics Inc | 2022-06-07 | 31,093 | 0.04 | 1,345 |
Holding Weightings of Stephen T Worland
Stephen T Worland Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen T Worland has made a total of 1 transactions in eFFECTOR Therapeutics Inc (EFTR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in eFFECTOR Therapeutics Inc is the acquisition of 800 shares on June 7, 2022, which cost Stephen T Worland around $27,400.
Insider Trading History of Stephen T Worland
- 1
Stephen T Worland Trading Performance
GuruFocus tracks the stock performance after each of Stephen T Worland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen T Worland is -58.5%. GuruFocus also compares Stephen T Worland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen T Worland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen T Worland's insider trading performs compared to the benchmark.
Performance of Stephen T Worland
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.69 | | | | | |
| Relative Return to S&P 500(%) | 13.89 | | | | | |
Stephen T Worland Ownership Network
Stephen T Worland Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Stephen T Worland is the director of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Stephen T Worland made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. , and a net purchase of 50,999 shares made by Charles Theuer .
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 2,550 shares were bought by its insiders, resulting in a net sale of 235,650 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Stephen T Worland Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen T Worland. You might contact Stephen T Worland via mailing address: 9050 Camino Santa Fe, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
